A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The study is investigating new medicines for weight control in people with high body weight. The study looks at how the study medicines work in the body. Participants will get semaglutide and either NNC0165‐1562 or "dummy" medicine ‐which treatment participants get is decided by chance. Participants will get 2 injections per week for 5 months. A study nurse at the clinic will inject the medicine with a thin needle in a skin fold in the stomach. The study will last for about 7 months. Participants will have 27 visits to the clinic.
Epistemonikos ID: 643b44dd53fd132df17bd3de77c6ae291e406ac3
First added on: May 21, 2024